Industry Research Reports
Home > Reports > Service & Software > Global Oocyte Cryopreservation Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Oocyte Cryopreservation Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-08
Pages: 140 Pages
Report ld: 4917838
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Oocyte Cryopreservation Market Size(US$)
CAGR 2025-2031
15.0%
Market Size,2031
USD 242
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 104 million
Market Forecast in 2031(Value)
US$ 242 million
CAGR
15.0%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Oocyte Cryopreservation market is projected to grow from US$ 92 million in 2024 to US$ 242 million by 2031, at a CAGR of 15.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Human oocyte cryopreservation (egg freezing) is a procedure to preserve a woman's eggs (oocytes).The eggs are extracted, frozen and stored. The intention of the procedure is that the woman may choose to have the eggs thawed, fertilized, and transferred to the uterus as embryos to facilitate a pregnancy in the future.
America is the largest region market with more than 75% market share in oocyte cryopreservation industry in Canada and USA regions. Top players are Prelude Fertility, CReATe Fertility Center, Anova Fertility, San Diego Fertility Center (SDFC), Extend Fertility, Shady Grove Fertility, Mayo Clinic, Reproductive Biology Associates, CCRM IVF, HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group), Kindbody, West Coast Fertility Centers etc.
The driving factors of the oocyte cryopreservation market mainly include the following aspects:
Technological progress: The continuous improvement and maturity of oocyte cryopreservation technology has improved the recovery rate and survival rate of frozen oocytes, thereby increasing the clinical application prospects of this technology and driving the development of the market.
Changes in fertility concepts: The changes in modern women's fertility concepts and the intensification of the trend of late marriage and late childbearing have led more and more women to choose oocyte cryopreservation technology to maintain fertility and provide guarantees for future fertility plans.
Growth in medical demand: With the improvement of medical standards and people's attention to reproductive health, more and more medical institutions and patients have begun to pay attention to oocyte cryopreservation technology, which has promoted the rapid development of the market.
Policy support: The support policies for assisted reproductive technology in some countries and regions, as well as the improvement of relevant laws and regulations, have provided a good policy environment for the development of oocyte cryopreservation technology.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Oocyte Cryopreservation market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Customer, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Prelude Fertility
- CReATe Fertility Center
- Anova Fertility
- San Diego Fertility Center (SDFC)
- Extend Fertility
- Shady Grove Fertility
- Mayo Clinic
- Reproductive Biology Associates
- CCRM IVF
- HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
- Kindbody
- West Coast Fertility Centers
- Ruizhimei
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Slow-cooling Method
- Flash-freezing Process (Vitrification)
Segment by Application
- 25-30 Year Old Female
- 30-35 Year Old Female
- 35-40 Year Old Female
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Oocyte Cryopreservation study scope, segments the market by Type and by Customer, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Customer, identifies emerging use cases, and profiles leading customers by region and by Customer.
Chapter 6: North America—breaks down market size by Type, by Customer and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Customer and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Customer, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Customer, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Customer, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Customer, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Oocyte Cryopreservation: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Oocyte Cryopreservation Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Slow-cooling Method
1.2.3 Flash-freezing Process (Vitrification)
1.3 Market Segmentation by Customer
1.3.1 Global Oocyte Cryopreservation Market Size by Customer, 2020 VS 2024 VS 2031
1.3.2 25-30 Year Old Female
1.3.3 30-35 Year Old Female
1.3.4 35-40 Year Old Female
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oocyte Cryopreservation Revenue Estimates and Forecasts 2020-2031
2.2 Global Oocyte Cryopreservation Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Oocyte Cryopreservation Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Oocyte Cryopreservation Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Slow-cooling Method Market Size by Players
3.3.2 Flash-freezing Process (Vitrification) Market Size by Players
3.4 Global Oocyte Cryopreservation Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Oocyte Cryopreservation Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Oocyte Cryopreservation Revenue by Customer
5.1.1 Global Historical and Forecasted Revenue by Customer (2020-2031)
5.1.2 Revenue Market Share by Customer (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Customer
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Oocyte Cryopreservation Market Size by Type (2020-2031)
6.4 North America Oocyte Cryopreservation Market Size by Customer (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Oocyte Cryopreservation Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Oocyte Cryopreservation Market Size by Type (2020-2031)
7.4 Europe Oocyte Cryopreservation Market Size by Customer (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Oocyte Cryopreservation Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Oocyte Cryopreservation Market Size by Type (2020-2031)
8.4 Asia-Pacific Oocyte Cryopreservation Market Size by Customer (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Oocyte Cryopreservation Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Oocyte Cryopreservation Market Size by Type (2020-2031)
9.4 Central and South America Oocyte Cryopreservation Market Size by Customer (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Oocyte Cryopreservation Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Oocyte Cryopreservation Market Size by Type (2020-2031)
10.4 Middle East and Africa Oocyte Cryopreservation Market Size by Customer (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Oocyte Cryopreservation Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Prelude Fertility
11.1.1 Prelude Fertility Corporation Information
11.1.2 Prelude Fertility Business Overview
11.1.3 Prelude Fertility Oocyte Cryopreservation Product Features and Attributes
11.1.4 Prelude Fertility Oocyte Cryopreservation Revenue and Gross Margin (2020-2025)
11.1.5 Prelude Fertility Oocyte Cryopreservation Revenue by Product in 2024
11.1.6 Prelude Fertility Oocyte Cryopreservation Revenue by Customer in 2024
11.1.7 Prelude Fertility Oocyte Cryopreservation Revenue by Geographic Area in 2024
11.1.8 Prelude Fertility Oocyte Cryopreservation SWOT Analysis
11.1.9 Prelude Fertility Recent Developments
11.2 CReATe Fertility Center
11.2.1 CReATe Fertility Center Corporation Information
11.2.2 CReATe Fertility Center Business Overview
11.2.3 CReATe Fertility Center Oocyte Cryopreservation Product Features and Attributes
11.2.4 CReATe Fertility Center Oocyte Cryopreservation Revenue and Gross Margin (2020-2025)
11.2.5 CReATe Fertility Center Oocyte Cryopreservation Revenue by Product in 2024
11.2.6 CReATe Fertility Center Oocyte Cryopreservation Revenue by Customer in 2024
11.2.7 CReATe Fertility Center Oocyte Cryopreservation Revenue by Geographic Area in 2024
11.2.8 CReATe Fertility Center Oocyte Cryopreservation SWOT Analysis
11.2.9 CReATe Fertility Center Recent Developments
11.3 Anova Fertility
11.3.1 Anova Fertility Corporation Information
11.3.2 Anova Fertility Business Overview
11.3.3 Anova Fertility Oocyte Cryopreservation Product Features and Attributes
11.3.4 Anova Fertility Oocyte Cryopreservation Revenue and Gross Margin (2020-2025)
11.3.5 Anova Fertility Oocyte Cryopreservation Revenue by Product in 2024
11.3.6 Anova Fertility Oocyte Cryopreservation Revenue by Customer in 2024
11.3.7 Anova Fertility Oocyte Cryopreservation Revenue by Geographic Area in 2024
11.3.8 Anova Fertility Oocyte Cryopreservation SWOT Analysis
11.3.9 Anova Fertility Recent Developments
11.4 San Diego Fertility Center (SDFC)
11.4.1 San Diego Fertility Center (SDFC) Corporation Information
11.4.2 San Diego Fertility Center (SDFC) Business Overview
11.4.3 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Product Features and Attributes
11.4.4 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Revenue and Gross Margin (2020-2025)
11.4.5 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Revenue by Product in 2024
11.4.6 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Revenue by Customer in 2024
11.4.7 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Revenue by Geographic Area in 2024
11.4.8 San Diego Fertility Center (SDFC) Oocyte Cryopreservation SWOT Analysis
11.4.9 San Diego Fertility Center (SDFC) Recent Developments
11.5 Extend Fertility
11.5.1 Extend Fertility Corporation Information
11.5.2 Extend Fertility Business Overview
11.5.3 Extend Fertility Oocyte Cryopreservation Product Features and Attributes
11.5.4 Extend Fertility Oocyte Cryopreservation Revenue and Gross Margin (2020-2025)
11.5.5 Extend Fertility Oocyte Cryopreservation Revenue by Product in 2024
11.5.6 Extend Fertility Oocyte Cryopreservation Revenue by Customer in 2024
11.5.7 Extend Fertility Oocyte Cryopreservation Revenue by Geographic Area in 2024
11.5.8 Extend Fertility Oocyte Cryopreservation SWOT Analysis
11.5.9 Extend Fertility Recent Developments
11.6 Shady Grove Fertility
11.6.1 Shady Grove Fertility Corporation Information
11.6.2 Shady Grove Fertility Business Overview
11.6.3 Shady Grove Fertility Oocyte Cryopreservation Product Features and Attributes
11.6.4 Shady Grove Fertility Oocyte Cryopreservation Revenue and Gross Margin (2020-2025)
11.6.5 Shady Grove Fertility Recent Developments
11.7 Mayo Clinic
11.7.1 Mayo Clinic Corporation Information
11.7.2 Mayo Clinic Business Overview
11.7.3 Mayo Clinic Oocyte Cryopreservation Product Features and Attributes
11.7.4 Mayo Clinic Oocyte Cryopreservation Revenue and Gross Margin (2020-2025)
11.7.5 Mayo Clinic Recent Developments
11.8 Reproductive Biology Associates
11.8.1 Reproductive Biology Associates Corporation Information
11.8.2 Reproductive Biology Associates Business Overview
11.8.3 Reproductive Biology Associates Oocyte Cryopreservation Product Features and Attributes
11.8.4 Reproductive Biology Associates Oocyte Cryopreservation Revenue and Gross Margin (2020-2025)
11.8.5 Reproductive Biology Associates Recent Developments
11.9 CCRM IVF
11.9.1 CCRM IVF Corporation Information
11.9.2 CCRM IVF Business Overview
11.9.3 CCRM IVF Oocyte Cryopreservation Product Features and Attributes
11.9.4 CCRM IVF Oocyte Cryopreservation Revenue and Gross Margin (2020-2025)
11.9.5 CCRM IVF Recent Developments
11.10 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
11.10.1 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Corporation Information
11.10.2 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Business Overview
11.10.3 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Product Features and Attributes
11.10.4 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Kindbody
11.11.1 Kindbody Corporation Information
11.11.2 Kindbody Business Overview
11.11.3 Kindbody Oocyte Cryopreservation Product Features and Attributes
11.11.4 Kindbody Oocyte Cryopreservation Revenue and Gross Margin (2020-2025)
11.11.5 Kindbody Recent Developments
11.12 West Coast Fertility Centers
11.12.1 West Coast Fertility Centers Corporation Information
11.12.2 West Coast Fertility Centers Business Overview
11.12.3 West Coast Fertility Centers Oocyte Cryopreservation Product Features and Attributes
11.12.4 West Coast Fertility Centers Oocyte Cryopreservation Revenue and Gross Margin (2020-2025)
11.12.5 West Coast Fertility Centers Recent Developments
11.13 Ruizhimei
11.13.1 Ruizhimei Corporation Information
11.13.2 Ruizhimei Business Overview
11.13.3 Ruizhimei Oocyte Cryopreservation Product Features and Attributes
11.13.4 Ruizhimei Oocyte Cryopreservation Revenue and Gross Margin (2020-2025)
11.13.5 Ruizhimei Recent Developments
12 Oocyte CryopreservationIndustry Chain Analysis
12.1 Oocyte Cryopreservation Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Oocyte Cryopreservation Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Oocyte Cryopreservation Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Oocyte Cryopreservation Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Oocyte Cryopreservation Market Size Growth Rate by Customer, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Oocyte Cryopreservation Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Oocyte Cryopreservation Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Oocyte Cryopreservation Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Oocyte Cryopreservation Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Oocyte Cryopreservation Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Oocyte Cryopreservation by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oocyte Cryopreservation as of 2024)
Table 11. Global Oocyte Cryopreservation Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Oocyte Cryopreservation Companies Headquarters
Table 13. Global Oocyte Cryopreservation Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Oocyte Cryopreservation Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Oocyte Cryopreservation Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Oocyte Cryopreservation Revenue by Customer (2020-2025) & (US$ Million)
Table 20. Global Oocyte Cryopreservation Revenue by Customer (2026-2031) & (US$ Million)
Table 21. Oocyte Cryopreservation High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Customer
Table 24. North America Oocyte Cryopreservation Growth Accelerators and Market Barriers
Table 25. North America Oocyte Cryopreservation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Oocyte Cryopreservation Growth Accelerators and Market Barriers
Table 27. Europe Oocyte Cryopreservation Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Oocyte Cryopreservation Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Oocyte Cryopreservation Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Oocyte Cryopreservation Investment Opportunities and Key Challenges
Table 31. Central and South America Oocyte Cryopreservation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Oocyte Cryopreservation Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Oocyte Cryopreservation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Prelude Fertility Corporation Information
Table 35. Prelude Fertility Description and Major Businesses
Table 36. Prelude Fertility Product Features and Attributes
Table 37. Prelude Fertility Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Prelude Fertility Revenue Proportion by Product in 2024
Table 39. Prelude Fertility Revenue Proportion by Customer in 2024
Table 40. Prelude Fertility Revenue Proportion by Geographic Area in 2024
Table 41. Prelude Fertility Oocyte Cryopreservation SWOT Analysis
Table 42. Prelude Fertility Recent Developments
Table 43. CReATe Fertility Center Corporation Information
Table 44. CReATe Fertility Center Description and Major Businesses
Table 45. CReATe Fertility Center Product Features and Attributes
Table 46. CReATe Fertility Center Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. CReATe Fertility Center Revenue Proportion by Product in 2024
Table 48. CReATe Fertility Center Revenue Proportion by Customer in 2024
Table 49. CReATe Fertility Center Revenue Proportion by Geographic Area in 2024
Table 50. CReATe Fertility Center Oocyte Cryopreservation SWOT Analysis
Table 51. CReATe Fertility Center Recent Developments
Table 52. Anova Fertility Corporation Information
Table 53. Anova Fertility Description and Major Businesses
Table 54. Anova Fertility Product Features and Attributes
Table 55. Anova Fertility Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Anova Fertility Revenue Proportion by Product in 2024
Table 57. Anova Fertility Revenue Proportion by Customer in 2024
Table 58. Anova Fertility Revenue Proportion by Geographic Area in 2024
Table 59. Anova Fertility Oocyte Cryopreservation SWOT Analysis
Table 60. Anova Fertility Recent Developments
Table 61. San Diego Fertility Center (SDFC) Corporation Information
Table 62. San Diego Fertility Center (SDFC) Description and Major Businesses
Table 63. San Diego Fertility Center (SDFC) Product Features and Attributes
Table 64. San Diego Fertility Center (SDFC) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. San Diego Fertility Center (SDFC) Revenue Proportion by Product in 2024
Table 66. San Diego Fertility Center (SDFC) Revenue Proportion by Customer in 2024
Table 67. San Diego Fertility Center (SDFC) Revenue Proportion by Geographic Area in 2024
Table 68. San Diego Fertility Center (SDFC) Oocyte Cryopreservation SWOT Analysis
Table 69. San Diego Fertility Center (SDFC) Recent Developments
Table 70. Extend Fertility Corporation Information
Table 71. Extend Fertility Description and Major Businesses
Table 72. Extend Fertility Product Features and Attributes
Table 73. Extend Fertility Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Extend Fertility Revenue Proportion by Product in 2024
Table 75. Extend Fertility Revenue Proportion by Customer in 2024
Table 76. Extend Fertility Revenue Proportion by Geographic Area in 2024
Table 77. Extend Fertility Oocyte Cryopreservation SWOT Analysis
Table 78. Extend Fertility Recent Developments
Table 79. Shady Grove Fertility Corporation Information
Table 80. Shady Grove Fertility Description and Major Businesses
Table 81. Shady Grove Fertility Product Features and Attributes
Table 82. Shady Grove Fertility Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Shady Grove Fertility Recent Developments
Table 84. Mayo Clinic Corporation Information
Table 85. Mayo Clinic Description and Major Businesses
Table 86. Mayo Clinic Product Features and Attributes
Table 87. Mayo Clinic Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Mayo Clinic Recent Developments
Table 89. Reproductive Biology Associates Corporation Information
Table 90. Reproductive Biology Associates Description and Major Businesses
Table 91. Reproductive Biology Associates Product Features and Attributes
Table 92. Reproductive Biology Associates Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Reproductive Biology Associates Recent Developments
Table 94. CCRM IVF Corporation Information
Table 95. CCRM IVF Description and Major Businesses
Table 96. CCRM IVF Product Features and Attributes
Table 97. CCRM IVF Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. CCRM IVF Recent Developments
Table 99. HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Corporation Information
Table 100. HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Description and Major Businesses
Table 101. HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Product Features and Attributes
Table 102. HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Recent Developments
Table 104. Kindbody Corporation Information
Table 105. Kindbody Description and Major Businesses
Table 106. Kindbody Product Features and Attributes
Table 107. Kindbody Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Kindbody Recent Developments
Table 109. West Coast Fertility Centers Corporation Information
Table 110. West Coast Fertility Centers Description and Major Businesses
Table 111. West Coast Fertility Centers Product Features and Attributes
Table 112. West Coast Fertility Centers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. West Coast Fertility Centers Recent Developments
Table 114. Ruizhimei Corporation Information
Table 115. Ruizhimei Description and Major Businesses
Table 116. Ruizhimei Product Features and Attributes
Table 117. Ruizhimei Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Ruizhimei Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Oocyte Cryopreservation Product Picture
Figure 2. Global Oocyte Cryopreservation Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Slow-cooling Method Product Picture
Figure 4. Flash-freezing Process (Vitrification) Product Picture
Figure 5. Global Oocyte Cryopreservation Market Size Growth Rate by Customer, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. 25-30 Year Old Female
Figure 7. 30-35 Year Old Female
Figure 8. 35-40 Year Old Female
Figure 9. Others
Figure 10. Oocyte Cryopreservation Report Years Considered
Figure 11. Global Oocyte Cryopreservation Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 13. Global Oocyte Cryopreservation Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Oocyte Cryopreservation Revenue Market Share by Region (2020-2031)
Figure 15. Global Oocyte Cryopreservation Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Slow-cooling Method Revenue Market Share by Player in 2024
Figure 18. Flash-freezing Process (Vitrification) Revenue Market Share by Player in 2024
Figure 19. Global Oocyte Cryopreservation Revenue Market Share by Type (2020-2031)
Figure 20. Global Oocyte Cryopreservation Revenue Market Share by Customer (2020-2031)
Figure 21. North America Oocyte Cryopreservation Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players Oocyte Cryopreservation Revenue (US$ Million) in 2024
Figure 23. North America Oocyte Cryopreservation Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America Oocyte Cryopreservation Revenue (US$ Million) by Customer (2020-2031)
Figure 25. US Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 26. Canada Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 28. Europe Oocyte Cryopreservation Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players Oocyte Cryopreservation Revenue (US$ Million) in 2024
Figure 30. Europe Oocyte Cryopreservation Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe Oocyte Cryopreservation Revenue (US$ Million) by Customer (2020-2031)
Figure 32. Germany Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 33. France Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 35. Italy Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 36. Russia Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Oocyte Cryopreservation Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players Oocyte Cryopreservation Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific Oocyte Cryopreservation Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific Oocyte Cryopreservation Revenue (US$ Million) by Customer (2020-2031)
Figure 41. Indonesia Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 42. Japan Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 44. Australia Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 45. India Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore Oocyte Cryopreservation Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America Oocyte Cryopreservation Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players Oocyte Cryopreservation Revenue (US$ Million) in 2024
Figure 53. Central and South America Oocyte Cryopreservation Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America Oocyte Cryopreservation Revenue (US$ Million) by Customer (2020-2031)
Figure 55. Brazil Oocyte Cryopreservation Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina Oocyte Cryopreservation Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa Oocyte Cryopreservation Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players Oocyte Cryopreservation Revenue (US$ Million) in 2024
Figure 59. South America Oocyte Cryopreservation Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa Oocyte Cryopreservation Revenue (US$ Million) by Customer (2020-2031)
Figure 61. GCC Countries Oocyte Cryopreservation Revenue (2020-2025) & (US$ Million)
Figure 62. Israel Oocyte Cryopreservation Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt Oocyte Cryopreservation Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa Oocyte Cryopreservation Revenue (2020-2025) & (US$ Million)
Figure 65. Oocyte Cryopreservation Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Oocyte Cryopreservation in 2031?
The global market size of Oocyte Cryopreservation in 2031 was 242 Million USD.
Which region is expected to have the highest market share?
What was the global market size of Oocyte Cryopreservation in 2025?
Which companies rank high in the global Oocyte Cryopreservation market?
What is the annual compound growth rate of the global Oocyte Cryopreservation market size from 2025 to 2031?
Related Reports
Global Oocyte Cryopreservation Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Oocyte Cryopreservation market size was US$ 104 million in 2025 and is forecast to reach a readjusted size of US$ 274 million by 2032 with a CAGR of 15.0% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 97
USD 4250.00
(Single User License)
Global Oocyte Cryopreservation Market Research Report 2026
The global Oocyte Cryopreservation market was valued at US$ 104 million in 2025 and is anticipated to reach US$ 274 million by 2032, at a CAGR of 15.0% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 114
USD 2900.00
(Single User License)
Oocyte Cryopreservation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oocyte Cryopreservation was estimated to be worth US$ 104 million in 2025 and is projected to reach US$ 274 million, growing at a CAGR of 15.0% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 110
USD 3950.00
(Single User License)
Global Oocyte Cryopreservation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oocyte Cryopreservation market size was US$ 92 million in 2024 and is forecast to a readjusted size of US$ 242 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 93
USD 4250.00
(Single User License)
Oocyte Cryopreservation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oocyte Cryopreservation was estimated to be worth US$ 92 million in 2024 and is forecast to a readjusted size of US$ 242 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 112
USD 3950.00
(Single User License)
Global Oocyte Cryopreservation Market Research Report 2025
The global market for Oocyte Cryopreservation was valued at US$ 92 million in the year 2024 and is projected to reach a revised size of US$ 242 million by 2031, growing at a CAGR of 15.0% during the forecast period.
Published Date: 2025-01-19
Pages: 90
USD 2900.00
(Single User License)
Global and China Oocyte Cryopreservation Market Report & Forecast 2024-2030
The global Oocyte Cryopreservation revenue was US$ 81 million in 2023 and is forecast to a readjusted size of US$ 213 million by 2030 with a CAGR of 15.0% during the review period (2024-2030).
Published Date: 2024-11-29
Pages: 113
USD 4350.00
(Single User License)
Oocyte Cryopreservation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Oocyte Cryopreservation was estimated to be worth US$ 81 million in 2023 and is forecast to a readjusted size of US$ 213 million by 2030 with a CAGR of 15.0% during the forecast period 2024-2030.
Published Date: 2024-11-29
Pages: 104
USD 3950.00
(Single User License)
Global Oocyte Cryopreservation Market Insights, Forecast to 2030
Valued at US$ 92 million in 2024, the global Oocyte Cryopreservation market is forecast to reach US$ 213 million by 2030, at a CAGR of 15.0% during the forecast period.
Published Date: 2024-11-29
Pages: 142
USD 4900.00
(Single User License)
Global Oocyte Cryopreservation Market Research Report 2024
The global market for Oocyte Cryopreservation was valued at US$ 81 million in the year 2023 and is projected to reach a revised size of US$ 213 million by 2030, growing at a CAGR of 15.0% during the forecast period.
Published Date: 2024-11-29
Pages: 90
USD 2900.00
(Single User License)
Global Oocyte Cryopreservation Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Oocyte Cryopreservation market size was US$ 104 million in 2025 and is forecast to reach a readjusted size of US$ 274 million by 2032 with a CAGR of 15.0% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 97
USD 4250.00 (Single User License)Global Oocyte Cryopreservation Market Research Report 2026
The global Oocyte Cryopreservation market was valued at US$ 104 million in 2025 and is anticipated to reach US$ 274 million by 2032, at a CAGR of 15.0% from 2026 to 2032.
Published: 2026-01-05
Pages: 114
USD 2900.00 (Single User License)Oocyte Cryopreservation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oocyte Cryopreservation was estimated to be worth US$ 104 million in 2025 and is projected to reach US$ 274 million, growing at a CAGR of 15.0% from 2026 to 2032.
Published: 2026-01-05
Pages: 110
USD 3950.00 (Single User License)Global Oocyte Cryopreservation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oocyte Cryopreservation market size was US$ 92 million in 2024 and is forecast to a readjusted size of US$ 242 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 93
USD 4250.00 (Single User License)Oocyte Cryopreservation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oocyte Cryopreservation was estimated to be worth US$ 92 million in 2024 and is forecast to a readjusted size of US$ 242 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 112
USD 3950.00 (Single User License)Global Oocyte Cryopreservation Market Research Report 2025
The global market for Oocyte Cryopreservation was valued at US$ 92 million in the year 2024 and is projected to reach a revised size of US$ 242 million by 2031, growing at a CAGR of 15.0% during the forecast period.
Published: 2025-01-19
Pages: 90
USD 2900.00 (Single User License)Global and China Oocyte Cryopreservation Market Report & Forecast 2024-2030
The global Oocyte Cryopreservation revenue was US$ 81 million in 2023 and is forecast to a readjusted size of US$ 213 million by 2030 with a CAGR of 15.0% during the review period (2024-2030).
Published: 2024-11-29
Pages: 113
USD 4350.00 (Single User License)Oocyte Cryopreservation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Oocyte Cryopreservation was estimated to be worth US$ 81 million in 2023 and is forecast to a readjusted size of US$ 213 million by 2030 with a CAGR of 15.0% during the forecast period 2024-2030.
Published: 2024-11-29
Pages: 104
USD 3950.00 (Single User License)Global Oocyte Cryopreservation Market Insights, Forecast to 2030
Valued at US$ 92 million in 2024, the global Oocyte Cryopreservation market is forecast to reach US$ 213 million by 2030, at a CAGR of 15.0% during the forecast period.
Published: 2024-11-29
Pages: 142
USD 4900.00 (Single User License)Global Oocyte Cryopreservation Market Research Report 2024
The global market for Oocyte Cryopreservation was valued at US$ 81 million in the year 2023 and is projected to reach a revised size of US$ 213 million by 2030, growing at a CAGR of 15.0% during the forecast period.
Published: 2024-11-29
Pages: 90
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now